Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026)
Intuitive Surgical (ISRG) recorded quarterly Income from Non-Controlling Interests of $5.0 million in Q1 2026, up 21.95% quarter-over-quarter from $4.1 million in Q4 2025, and down 7.41% on a YoY basis from $5.4 million in Q1 2025.
Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
Intuitive Surgical's Income from Non-Controlling Interests history runs 10 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 7.41% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $19.7 million (up 8.84% YoY), while the FY2025 annual figure was $20.6 million, up 38.26% from the prior year.
- Income from Non-Controlling Interests was $5.0 million for Q1 2026 at Intuitive Surgical, up from $4.1 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $11.8 million in Q4 2022 to a low of $700000.0 in Q3 2022.
- Historically, Income from Non-Controlling Interests has averaged $4.8 million across 5 years, with a median of $4.8 million in 2025.
- Biggest YoY gain for Income from Non-Controlling Interests was 461.9% in 2022; the steepest drop was 89.55% in 2022.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $11.8 million in 2022, then tumbled by 61.86% to $4.5 million in 2023, then sank by 48.89% to $2.3 million in 2024, then jumped by 78.26% to $4.1 million in 2025, then gained by 21.95% to $5.0 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $5.0 million (Q1 2026), $4.1 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 5.80 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 4.50 Mn |
| Sep 30, 2023 | 3.90 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 5.50 Mn |
| Dec 31, 2022 | 11.80 Mn |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 5.80 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 6.70 Mn |
| Jun 30, 2021 | 5.80 Mn |